Literature DB >> 16880351

Metabolic syndrome may not associate with carotid plaque in subjects with optimal, normal, or high-normal blood pressure.

Nobukazu Ishizaka1, Yuko Ishizaka, Hideki Hashimoto, Ei-Ichi Toda, Ryozo Nagai, Minoru Yamakado.   

Abstract

Much evidence indicates that metabolic syndrome is a risk factor for the development of cardiovascular disease, but whether metabolic syndrome is an independent risk factor for early atherosclerosis in the individuals with only minor hemodynamic abnormalities, if any, is not well investigated. Here we have investigated the association between metabolic syndrome and carotid atherosclerosis in individuals with blood pressure of <140/90 mm Hg. Between 1994 and 2003, 8143 subjects underwent general health screening including carotid ultrasonography. Of 8143 individuals, 5661 individuals without antihypertensive medications who had blood pressure of <140/90 mm Hg were considered to have optimal, normal, or high-normal blood pressure. After adjustment for age, systolic blood pressure, body mass index, total and high-density lipoprotein cholesterol, triglycerides, fasting glucose, and smoking status, metabolic syndrome was not found to be an independent risk factor for carotid plaque (odds ratio: 1.65; 95% CI; 0.72 to 3.76 in women and odds ratio: 0.95; 95% CI: 0.70 to 1.28 in men) or for carotid intima-media thickening (odds ratio: 0.56; 95% CI: 0.18 to 1.72 in women and odds ratio: 0.93 95% CI: 0.62 to 1.38 in men) in these subjects. Thus, presence of metabolic syndrome may not increase the prevalence of carotid atherosclerosis independent of other cardiovascular risk factors in Japanese individuals with optimal, normal, or high-normal blood pressure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16880351     DOI: 10.1161/01.HYP.0000233466.24345.2e

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  4 in total

1.  Associations between carotid artery wall thickness and cardiovascular risk factors using multidetector CT.

Authors:  L Saba; R Sanfilippo; R Montisci; G Mallarini
Journal:  AJNR Am J Neuroradiol       Date:  2010-07-15       Impact factor: 3.825

2.  Impact of metabolic syndrome on distribution of cervicocephalic atherosclerosis: data from a diverse race-ethnic group.

Authors:  Oh Young Bang; Jeffrey L Saver; David S Liebeskind; Sandra Pineda; Susan W Yun; Bruce Ovbiagele
Journal:  J Neurol Sci       Date:  2009-04-26       Impact factor: 3.181

3.  The prevalence of carotid plaque with different stability and its association with metabolic syndrome in China: The Asymptomatic Polyvascular Abnormalities Community study.

Authors:  Anxin Wang; Lingyun Wu; Xiaoxue Liu; Zhaoping Su; Yanxia Luo; Shuohua Chen; Haibin Li; Xiangtong Liu; Lixin Tao; Jin Guo; Feng Zhang; Yibin Cao; Xingquan Zhao; Shouling Wu; Xiuhua Guo
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

4.  Metabolic syndrome less strongly associated with target organ damage than syndrome components in a healthy, working population.

Authors:  Kazuo Eguchi; Joseph E Schwartz; Mary J Roman; Richard B Devereux; William Gerin; Thomas G Pickering
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-05       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.